Taylor & Francis LTD provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of Journal of drug targeting (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Journal of drug targeting published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Pharmacology & Pharmacyrank 53 of 371 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Journal of drug targeting
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Journal of drug targeting is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
02Review time
Review time of Journal of drug targeting
Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.
Half of the research articles Journal of drug targeting published between Jul 2025 and Oct 2026 were accepted within 98 days of submission, and the middle half took between 69 and 136 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.
In Pharmacology & Pharmacy, Journal of drug targeting ranks 61 of 157 journals by review time (1 = fastest). See the fastest-review journals in Pharmacology & Pharmacy →
03Fee waivers
APC waivers and discounts for Journal of drug targeting
Journal of drug targeting follows the waiver policy of its publisher, Taylor & Francis: 100% waiver for low-income and 50% for lower-middle income countries (World Bank list with a GDP limit), on request. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver.
Authors affiliated in 24 countries qualify for a full waiver. See the countries →
Waivers apply to fully open access journals. If Journal of drug targeting is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Retractions and research integrity at Journal of drug targeting
Retractions per year
Most common reasons (a retraction can have several):
Journal of drug targeting has 8 retracted papers in the Retraction Watch database, the latest in May 2025. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
Who funds research published in Journal of drug targeting
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
Submitting to Journal of drug targeting? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
04Indexing
Indexing of Journal of drug targeting
- ISSN
- 1061-186X
- eISSN
- 1029-2330
- Publisher
- Taylor & Francis LTD all its journals →
- Country
- England
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Pharmacology & Pharmacy
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
05How to submit
How to submit to Journal of drug targeting
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Journal of drug targeting accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Use the journal's template. Taylor & Francis LTD offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Journal of drug targeting is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
06Reviewer comments
Reviewer comments and rejection reasons for Journal of drug targeting
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Journal of drug targeting, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
07Same subject
Pharmacology & Pharmacy journals with a similar impact factor*
The journals next to Journal of drug targeting when the 354 journals of Pharmacology & Pharmacy in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 49 | Journal of Ethnopharmacology | 5.70 | SCIE | Subscription |
| 50 | Expert Opinion on Therapeutic Patents | 5.66 | SCIE | Subscription |
| 51 | Neurotherapeutics | 5.62 | SCIE | Fully open access |
| 52 | European Journal of Pharmaceutics and Biopharmaceutics | 5.55 | SCIE | Subscription |
| 54 | Biomedicines | 5.31 | SCIE | Fully open access |
| 55 | Molecular Pharmaceutics | 5.21 | SCIE | Subscription |
| 56 | Frontiers in Pharmacology | 5.17 | SCIE | Fully open access |
| 57 | ADMET & DMPK | 5.17 | ESCI | Fully open access |
*Impact factor calculated from OpenAlex open data (2-year citedness), not the official Clarivate value.
08Journal Finder
Find the right journal for your paper
Is Journal of drug targeting right for your paper? Compare journals
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,724 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated from OpenAlex open data, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time comes from the dates publishers deposit in Crossref (not every publisher deposits them). Always check a journal’s scope and current indexing before submitting.
09Questions
Frequently asked questions
How long is the review time of Journal of drug targeting?
Based on 196 research articles Journal of drug targeting published from Jul 2025 to Oct 2026, the median time from submission to acceptance was 98 days, and half of them were accepted between 69 and 136 days. After acceptance, papers appeared online after a median of 16 days. Source: received and accepted dates deposited by the publisher in Crossref, retrieved October 2026. Individual papers can take longer, especially with major revisions.
What is the impact factor of Journal of drug targeting?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Journal of drug targeting is 5.38: papers it published in the two previous years were cited 5.38 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Journal of drug targeting?
The h-index of Journal of drug targeting is 119 (OpenAlex, October 2026): 119 of its papers have each been cited at least 119 times. Its i10-index is 1,914.
What is the quartile of Journal of drug targeting?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Journal of drug targeting is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Journal of drug targeting indexed in Scopus?
Yes. Journal of drug targeting appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Journal of drug targeting an SCIE journal?
Yes. Journal of drug targeting is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Journal of drug targeting in Journal Citation Reports (JCR)?
Yes. Journal of drug targeting is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Journal of drug targeting offer an APC waiver?
Journal of drug targeting follows the policy of Taylor & Francis: 100% waiver for low-income and 50% for lower-middle income countries (World Bank list with a GDP limit), on request. Only the corresponding author's affiliation counts. Co-authors from other countries do not change the waiver. Rules verified 27 October 2026; confirm on the publisher's page.
Has Journal of drug targeting retracted papers?
Yes. The Retraction Watch database lists 8 retracted papers in Journal of drug targeting, 4 of them in the last 10 years; the most common reasons are results not reproducible, duplication of/in image, error in methods. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in Journal of drug targeting?
47% of 200 recent research articles in Journal of drug targeting name a funder in Crossref; the funders named most often are National Natural Science Foundation of China, Taif University, Saudi Arabia, Prince Sattam bin Abdulaziz University.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Physics Letters A
- Journal of Alloys and Compounds
- Biophysical Journal
- International Journal of Biological Macromolecules
- Journal of Molecular Structure
- Zootaxa
- Chemical Engineering Journal
- Medicine
- Astrophysical Journal
- Chemosphere
- Journal of Physical Chemistry
- Neurology
- Journal of Applied Physics
- RSC Advances
Browse all journals: indexing, impact factor and reviewer comments →